Open-label trial of imatinib mesylate (Glivec, formerly known as STI571) in combination with vinorelbine (Navelbine) for patients with advanced breast carcinoma

Update Il y a 4 ans
Reference: EUCTR2005-001537-15

Woman Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess the safety and tolerability of Glivec in combination with Vinorelbine in patients with progressive or metastatic breast cancer after previous anthracycline chemotherapy.


Inclusion criteria

  • carcinoma breast

Links